- Home
- Applications
- canada nunavut
- disease target
Show results for
Refine by
Disease Target Product Applications Available In Canada Nunavut
4 applications found
Rodent mammary carcinoma, mice lung cancer, glioma and pancreatic cancer are just some targeted diseases in preclinical testing using exosome delivery technology. Examples of peptides and targeting ligands for exosome decoration are integrin specific RGD for mice mammary tumor or GE11 synthetic peptide for EGFR+ breast ...
ByNanovex Biotechnologies based in Llanera, SPAIN
Our platform delivers investigational medicinal products that contain diverse and viable communities of donor-derived microorganisms that target multiple functional pathways. We believe that this approach is superior to others being pursued and provides the company with numerous competitive advantages, including: de-risking of clinical programmes based on IMT precedence, accelerated clinical development and opportunities to discover second and third generation products through data generated from clinical ...
ByEnteroBiotix Ltd based in Glasgow, UNITED KINGDOM
Using our platform, we are developing mRNA medicines for diverse uses and delivering them to patients across the globe. We are currently focusing on 4 medical areas - infectious diseases, immuno-oncology, rare diseases and autoimmune ...
ByModerna, Inc. based in Cambridge, MASSACHUSETTS (USA)
Fractyl Health was founded in 2011 with a dedication to developing novel therapeutic interventions that have the potential to help reverse the metabolic disease epidemic. Despite advances in treatment over the past 50 years, metabolic diseases in general, and type 2 diabetes (T2D) in particular, continue to be a principal and rapidly growing driver of morbidity and mortality in the 21st century. Our goal is to transform T2D treatment from chronic blood glucose management to ...
ByFractyl Health based in Lexington, MASSACHUSETTS (USA)